We serve N’-Cbz-L-lysine tert-butyl ester hydrochloride CAS:5978-22-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: N'-Cbz-L-lysine tert-butyl ester hydrochloride
CAS.NO: 5978-22-3
Molecular Formula:C18H29ClN2O4
Molecular Weight: 372.88700
Synonyms:
tert-butyl (2S)-2-amino-6-(phenylmethoxycarbonylamino)hexanoate,hydrochloride
(2S)-6-{[(Benzyloxy)carbonyl]amino}-1-[(2-methyl-2-propanyl)oxy]-1-oxo-2-hexanaminium chloride
Physical and Chemical Properties:
Density:/
Boiling point: 469.6ºC at 760 mmHg
Flash point: 237.8ºC
Refractive index:/
Specification:
Appearance: White Crystalline Powder
Purity:≥98%
Loss on drying:0.20% max.
Residue on ignition[sulfated]:0.10% max.
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:-15 ℃ protected from light, cool and dry place, sealed and stored.
Application:Pharmaceutical intermediates.
Contact us for information like N’-Cbz-L-lysine tert-butyl ester hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2S)-6-{[(Benzyloxy)carbonyl]amino}-1-[(2-methyl-2-propanyl)oxy]-1-oxo-2-hexanaminium chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2S)-6-{[(Benzyloxy)carbonyl]amino}-1-[(2-methyl-2-propanyl)oxy]-1-oxo-2-hexanaminium chloride Use and application,N’-Cbz-L-lysine tert-butyl ester hydrochloride technical grade,usp/ep/jp grade.
Related News: The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application.2-Fluoro-N-methylaniline manufacturer He added that the government raised the travel advice warning to level four, the highest, meaning they’re now advising people not to travel to mainland China. The warning aims to address “the issue of the human-to-human transmission of the coronavirus.”(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[[(2-phenylacetyl)amino]methylsulfanyl]propanoic acid supplier Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.2-(4-Fluorophenyl)thiophene vendor Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.
